Report Overview
The global Commercial Drug Procurement market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030. LPI (LP Information)' newest research report, the ?Commercial Drug Procurement Industry Forecast? looks at past sales and reviews total world Commercial Drug Procurement sales in 2022, providing a comprehensive analysis by region and market sector of projected Commercial Drug Procurement sales for 2023 through 2029. With Commercial Drug Procurement sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Commercial Drug Procurement industry. This Insight Report provides a comprehensive analysis of the global Commercial Drug Procurement landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Commercial Drug Procurement portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Commercial Drug Procurement market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Commercial Drug Procurement and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Commercial Drug Procurement. United States market for Commercial Drug Procurement is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. China market for Commercial Drug Procurement is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Europe market for Commercial Drug Procurement is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030. Global key Commercial Drug Procurement players cover Viseven, Bionical Emas, Almac, BMclinical, Myonex, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023. This report presents a comprehensive overview, market shares, and growth opportunities of Commercial Drug Procurement market by product type, application, key players and key regions and countries. Segmentation by Type: Tender Direct Procurement Competitive Negotiation Others Segmentation by Application: Life Sciences Clinical Trials Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries Segmentation by Type: Tender Direct Procurement Competitive Negotiation Others Segmentation by Application: Life Sciences Clinical Trials Others This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Viseven Bionical Emas Almac BMclinical Myonex McKesson Parexel Patheon Clinigen UPS Healthcare Catalent Endpoint Clinical Signant Health YPrime
Table Of Contents
Table of Content 1 Introduction 1.1 Objective of the Study 1.2 Definition of the Market 1.3 Market Scope 1.3.1 Market Segment by Type, Application and Marketing Channel 1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa) 1.4 Years Considered for the Study (2017-2029) 1.5 Currency Considered (U.S. Dollar) 1.6 Stakeholders 2 Key Findings of the Study 3 Market Dynamics 3.1 Driving Factors for this Market 3.2 Factors Challenging the Market 3.3 Opportunities of the Global Commercial Drug Procurement Market (Regions, Growing/Emerging Downstream Market Analysis) 3.4 Technological and Market Developments in the Commercial Drug Procurement Market 3.5 Industry News by Region 3.6 Regulatory Scenario by Region/Country 3.7 Market Investment Scenario Strategic Recommendations Analysis 4 Value Chain of the Commercial Drug Procurement Market 4.1 Value Chain Status 4.2 Upstream Raw Material Analysis 4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type) 4.4 Distributors/Traders 4.5 Downstream Major Customer Analysis (by region) 5 Global Commercial Drug Procurement Market-Segmentation by Type 5.1 Type 1 5.2 Type 2 5.3 Type 3 6 Global Commercial Drug Procurement Market-Segmentation by Application 6.1 Application 1 6.2 Application 2 6.3 Application 3 7 Global Commercial Drug Procurement Market-Segmentation by Marketing Channel 7.1 Traditional Marketing Channel (Offline) 7.2 Online Channel 8 Competitive Intelligence A Company Profiles 8.1 Company 1 8.1.1 Company 1 Profile 8.1.2 Company 1 Sales, Growth Rate and Global Market Share from 2017-2023 8.1.3 Company 1 Product/Solution Launches and Enhancements Analysis 8.1.4 Company 1 Business Overview/Recent Development/Acquisitions 8.2 Company 2 8.2.1 Company 2 Profile 8.2.2 Company 2 Sales, Growth Rate and Global Market Share from 2017-2023 8.2.3 Company 2 Product/Solution Launches and Enhancements Analysis 8.2.4 Company 2 Business Overview/Recent Development/Acquisitions 8.3 Company 3 8.3.1 Company 3 Profile 8.3.2 Company 3 Sales, Growth Rate and Global Market Share from 2017-2023 8.3.3 Company 3 Product/Solution Launches and Enhancements Analysis 8.3.4 Company 3 Business Overview/Recent Development/Acquisitions 8.4 Company 4 8.4.1 Company 4 Profile 8.4.2 Company 4 Sales, Growth Rate and Global Market Share from 2017-2023 8.4.3 Company 4 Product/Solution Launches and Enhancements Analysis 8.4.4 Company 4 Business Overview/Recent Development/Acquisitions 8.5 Company 5 8.5.1 Company 5 Profile 8.5.2 Company 5 Sales, Growth Rate and Global Market Share from 2017-2023 8.5.3 Company 5 Product/Solution Launches and Enhancements Analysis 8.5.4 Company 5 Business Overview/Recent Development/Acquisitions 8.6 Company 6 8.6.1 Company 6 Profile 8.6.2 Company 6 Sales, Growth Rate and Global Market Share from 2017-2023 8.6.3 Company 6 Product/Solution Launches and Enhancements Analysis 8.6.4 Company 6 Business Overview/Recent Development/Acquisitions 8.7 Company 7 8.7.1 Company 7 Profile 8.7.2 Company 7 Sales, Growth Rate and Global Market Share from 2017-2023 8.7.3 Company 7 Product/Solution Launches and Enhancements Analysis 8.7.4 Company 7 Business Overview/Recent Development/Acquisitions 8.8 Company 8 8.8.1 Company 8 Profile 8.8.2 Company 8 Sales, Growth Rate and Global Market Share from 2017-2023 8.8.3 Company 8 Product/Solution Launches and Enhancements Analysis 8.8.4 Company 8 Business Overview/Recent Development/Acquisitions 8.9 Company 9 8.9.1 Company 9 Profile 8.9.2 Company 9 Sales, Growth Rate and Global Market Share from 2017-2023 8.9.3 Company 9 Product/Solution Launches and Enhancements Analysis 8.9.4 Company 9 Business Overview/Recent Development/Acquisitions 8.10 Company 10 8.10.1 Company 10 Profile 8.10.2 Company 10 Sales, Growth Rate and Global Market Share from 2017-2023 8.10.3 Company 10 Product/Solution Launches and Enhancements Analysis 8.10.4 Company 10 Business Overview/Recent Development/Acquisitions 8.11 Company 11 8.11.1 Company 11 Profile 8.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2017-2023 8.11.3 Company 11 Product/Solution Launches and Enhancements Analysis 8.11.4 Company 11 Business Overview/Recent Development/Acquisitions 8.12 Company 12 8.12.1 Company 12 Profile 8.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2017-2023 8.12.3 Company 12 Product/Solution Launches and Enhancements Analysis 8.12.4 Company 12 Business Overview/Recent Development/Acquisitions 8.13 Company 13 8.13.1 Company 13 Profile 8.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2017-2023 8.13.3 Company 13 Product/Solution Launches and Enhancements Analysis 8.13.4 Company 13 Business Overview/Recent Development/Acquisitions 8.14 Company 14 8.14.1 Company 14 Profile 8.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2017-2023 8.14.3 Company 14 Product/Solution Launches and Enhancements Analysis 8.14.4 Company 14 Business Overview/Recent Development/Acquisitions 8.15 Company 15 8.15.1 Company 15 Profile 8.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2017-2023 8.15.3 Company 15 Product/Solution Launches and Enhancements Analysis 8.15.4 Company 15 Business Overview/Recent Development/Acquisitions 9 Global Commercial Drug Procurement Market-Segmentation by Geography 10 North America 10.1 North America Commercial Drug Procurement Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 10.2 North America Commercial Drug Procurement Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 10.3 North America Commercial Drug Procurement Production Analysis from 2017-2023 10.4 North America Commercial Drug Procurement Consumption Analysis from 2017-2023 10.5 North America Commercial Drug Procurement Import and Export from 2017-2023 10.6 North America Commercial Drug Procurement Value, Production and Market Share by Type (2017-2023) 10.7 North America Commercial Drug Procurement Consumption, Value and Market Share by Application (2017-2023) 10.8 North America Commercial Drug Procurement by Country (United States, Canada) 10.8.1 North America Commercial Drug Procurement Sales by Country (2017-2023) 10.8.2 North America Commercial Drug Procurement Consumption Value by Country (2017-2023) 10.9 North America Commercial Drug Procurement Market PEST Analysis 11 Europe 11.1 Europe Commercial Drug Procurement Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 11.2 Europe Commercial Drug Procurement Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 11.3 Europe Commercial Drug Procurement Production Analysis from 2017-2023 11.4 Europe Commercial Drug Procurement Consumption Analysis from 2017-2023 11.5 Europe Commercial Drug Procurement Import and Export from 2017-2023 11.6 Europe Commercial Drug Procurement Value, Production and Market Share by Type (2017-2023) 11.7 Europe Commercial Drug Procurement Consumption, Value and Market Share by Application (2017-2023) 11.8 Europe Commercial Drug Procurement by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium) 11.8.1 Europe Commercial Drug Procurement Sales by Country (2017-2023) 11.8.2 Europe Commercial Drug Procurement Consumption Value by Country (2017-2023) 11.9 Europe Commercial Drug Procurement Market PEST Analysis 12 Asia-Pacific 12.1 Asia-Pacific Commercial Drug Procurement Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 12.2 Asia-Pacific Commercial Drug Procurement Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 12.3 Asia-Pacific Commercial Drug Procurement Production Analysis from 2017-2023 12.4 Asia-Pacific Commercial Drug Procurement Consumption Analysis from 2017-2023 12.5 Asia-Pacific Commercial Drug Procurement Import and Export from 2017-2023 12.6 Asia-Pacific Commercial Drug Procurement Value, Production and Market Share by Type (2017-2023) 12.7 Asia-Pacific Commercial Drug Procurement Consumption, Value and Market Share by Application (2017-2023) 12.8 Asia-Pacific Commercial Drug Procurement by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia) 12.8.1 Asia-Pacific Commercial Drug Procurement Sales by Country (2017-2023) 12.8.2 Asia-Pacific Commercial Drug Procurement Consumption Value by Country (2017-2023) 12.9 Asia-Pacific Commercial Drug Procurement Market PEST Analysis 13 Latin America 13.1 Latin America Commercial Drug Procurement Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 13.2 Latin America Commercial Drug Procurement Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 13.3 Latin America Commercial Drug Procurement Production Analysis from 2017-2023 13.4 Latin America Commercial Drug Procurement Consumption Analysis from 2017-2023 13.5 Latin America Commercial Drug Procurement Import and Export from 2017-2023 13.6 Latin America Commercial Drug Procurement Value, Production and Market Share by Type (2017-2023) 13.7 Latin America Commercial Drug Procurement Consumption, Value and Market Share by Application (2017-2023) 13.8 Latin America Commercial Drug Procurement by Country (Brazil, Mexico, Argentina, Columbia, Chile) 13.8.1 Latin America Commercial Drug Procurement Sales by Country (2017-2023) 13.8.2 Latin America Commercial Drug Procurement Consumption Value by Country (2017-2023) 13.9 Latin America Commercial Drug Procurement Market PEST Analysis 14 Middle East & Africa 14.1 Middle East & Africa Commercial Drug Procurement Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2017-2023 14.2 Middle East & Africa Commercial Drug Procurement Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2017-2023 14.3 Middle East & Africa Commercial Drug Procurement Production Analysis from 2017-2023 14.4 Middle East & Africa Commercial Drug Procurement Consumption Analysis from 2017-2023 14.5 Middle East & Africa Commercial Drug Procurement Import and Export from 2017-2023 14.6 Middle East & Africa Commercial Drug Procurement Value, Production and Market Share by Type (2017-2023) 14.7 Middle East & Africa Commercial Drug Procurement Consumption, Value and Market Share by Application (2017-2023) 14.8 Middle East & Africa Commercial Drug Procurement by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa) 14.8.1 Middle East & Africa Commercial Drug Procurement Sales by Country (2017-2023) 14.8.2 Middle East & Africa Commercial Drug Procurement Consumption Value by Country (2017-2023) 14.9 Middle East & Africa Commercial Drug Procurement Market PEST Analysis 15 Future Forecast of the Global Commercial Drug Procurement Market from 2023-2029 15.1 Future Forecast of the Global Commercial Drug Procurement Market from 2023-2029 Segment by Region 15.2 Global Commercial Drug Procurement Production and Growth Rate Forecast by Type (2023-2029) 15.3 Global Commercial Drug Procurement Consumption and Growth Rate Forecast by Application (2023-2029) 16 Appendix 16.1 Methodology 16.2 Research Data Source